Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.

N Kernan, Walter; M Viscoli, Catherine; L Furie, Karen; H Young, Lawrence; E Inzucchi, Silvio; Gorman, Mark; D Guarino, Peter; M Lovejoy, Anne; N Peduzzi, Peter; Conwit, Robin; M Brass, Lawrence; G Schwartz, Gregory; P Adams, Harold; Berger, Leo; Carolei, Antonio; Clark, Wayne; Coull, Bruce; A Ford, Gary; Kleindorfer, Dawn; R O'Leary, John; W Parsons, Mark; Ringleb, Peter; Sen, Souvik; David Spence, J; Tanne, David; Wang, David; R Winder, Toni; Trial Investigators, IRIS

doi:10.1056/nejmoa1506930

Public

Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.

Published in The New England journal of medicine • Apr 7, 2016

NobleIDark:/48914/w1/20260526/95B943FBRecord on NobleID

Authors:

Walter N Kernan

,

Catherine M Viscoli

,

Karen L Furie

Abstract

BACKGROUND: Patients with ischemic stroke or transient ischemic attack (TIA) are at increased risk for future cardiovascular events despite current preventive therapies. The identification of insulin resistance as a risk factor for stroke and myocardial infarction raised the possibility that pioglit...

Discussions